Delivery Order SPE2DU25D5132-SPE2DU26FA201
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $11,439.51 to AmerisourceBergen Drug Corp on August 26, 2025, with completion scheduled for August 27, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract covers pharmaceutical and medical supply...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,790.80 to AmerisourceBergen Drug Corp on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price delivery order, issued under a non-set-aside competitive procurement, represents a child contract executed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,790.80 to AmerisourceBergen Drug Corp on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp valued at $29,451.03 on October 13, 2025, with an ultimate completion date of October 14, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,664.83 to AmerisourceBergen Drug Corp on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $17,139.14 to AmerisourceBergen Drug Corp on April 22, 2025, with completion scheduled for April 23, 2025. This firm fixed price, non-set-aside delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $119,950.23 to AmerisourceBergen Drug Corp on September 18, 2025, with completion targeted for the same date. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion pharmaceutical support vehicle extending through December 2026. The delivery order will be...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $56,624.80 to AmerisourceBergen Drug Corp on October 13, 2025, with an ultimate completion date of October 14, 2025. This is a firm fixed-price, non-set-aside delivery order issued under contract number 4569742683. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $14,800.80 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract specifies...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $34,900.39 to AmerisourceBergen Drug Corp on September 26, 2025, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order, issued as a competitive award with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- SPE2DU25D5132Indefinite Delivery Contract
- SPE2DU25D5132-SPE2DU26FA201Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,062.47 to AmerisourceBergen Drug Corp on October 20, 2025, with an ultimate completion date of October 21, 2025. This contract is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which is also the headquarters of the prime contractor. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. Under its prime IDC with DLA, the contractor supplies a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's federal contract portfolio demonstrates extensive capability to fulfill diverse medical supply needs, with delivery orders ranging from small-value transactions to substantial orders exceeding $45,000, supporting customers including the Defense Health Agency and U.S. Coast Guard through a flexible and comprehensive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 10/20/25 |